937798-11-3

Upstream product

• 937798-10-2 4-[3-[3-(tert-butyldimethylsilanyloxy)-3-(4-fluorophenyl)propyl]-1-(4-fluorophenyl)-4-oxoazetidin-2-yl]-3-hydroxybenzylpiperazine-1-carbonate 

Downstream Products

• 937798-12-4 ammonium 4-(4-{1-(4-fluorophenyl)-3-[3-(4-fluorophenyl)-3-hydroxypropyl]-4-oxoazetidin-2-yl}-3-hydroxybenzyloxycarbonyl)piperazine-1-sulfamate 

Relevant academic research and scientific papers

Hydroxy-Substituted Diphenylazetidinones for the Treatment of Hyperlipidemia

The present invention comprises compounds and compositions for the treatment of metabolic disorders and more particularly, those insulin-related metabolic disorders of the blood such as hyperlipidemia, diabetes, insulin-resistance and the like comprising diphenylazetidinones compounds which have an additional hydroxy function in the 2″ position and their salts. The invention therefore relates to compounds of formula I: in which the meanings R1, R2, R3, R4, R5, R6 are defined herein.